MedPath

Chocolate and CVD Risk in Postmenopausal Women

Completed
Conditions
Stroke
Cardiovascular Disease
Heart Disease
Registration Number
NCT03453073
Lead Sponsor
Brooklyn College of the City University of New York
Brief Summary

The investigators will conduct an epidemiological analysis of data from the Women's Health Initiative to investigate the prospective association between chocolate intake and the risk of heart disease and stroke.

Detailed Description

BACKGROUND: Three recent meta-analyses found significant prospective inverse associations between chocolate intake and cardiovascular disease risk. Evidence from these meta-analyses suggests that such inverse associations may only apply to elderly individuals or those with preexisting major chronic disease.

OBJECTIVE: The investigators will assess the association between habitual chocolate intake and subsequent incident coronary heart disease (CHD) and stroke, and the potential effect of modification by age.

DESIGN: The investigators will conduct multivariable Cox regression analyses using data from 83,310 postmenopausal women free of baseline preexisting major chronic disease in the prospective Women's Health Initiative cohort. Chocolate intake was assessed using a food frequency questionnaire. Physician adjudicated events or deaths were ascertained up to September 30, 2013.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
83310
Inclusion Criteria
  1. Postmenopausal women
  2. age between 50 and 79 years
  3. enrolled in the Women's Health Initiative (WHI) Observational Study, or in the control arm of one or more overlapping WHI clinical trials.
Exclusion Criteria
  1. implausible energy intakes, defined as <600 kcal/d or >5,000 kcal/d;
  2. implausible body mass indices (BMI) (<15 or >50 kg/m2)
  3. implausible height<122 cm (4 ft.)
  4. self-reported preexisting serious chronic disease at baseline, including diabetes, angina, myocardial infarction (MI), stroke, heart failure, coronary artery bypass graft, percutaneous coronary intervention or cancer.
  5. missing data on preexisting major chronic disease or any exposure, outcome or confounder variables.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
incidence of heart diseasebetween the baseline survey (1993-8) & September 30, 2013, average 13.4 years

physician adjudicated first occurrence of, or death due to, heart disease

incidence of strokebetween the baseline survey (1993-8) & September 30, 2013, average 13.4 years

physician adjudicated first occurrence of, or death due to, stroke

incidence of heart disease or strokebetween the baseline survey (1993-8) & September 30, 2013, average 13.4 years

physician adjudicated first occurrence of, or death due to, heart disease or stroke

change in chocolate intaketime between the baseline and visit 3, average 3 years

change in chocolate intake between visit 1 and 3

change in dietary energy intaketime between the baseline and year 3, average 3 years

change in dietary energy intake between visit 1 and 3

change in dietary fat intaketime between the baseline and year 3, average 3 years

change in dietary fat intake between visit 1 and 3

change in BMItime between the baseline and year 3, average 3 years

change in BMI between visit 1 and 3

Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.